Guanqi Dai

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Wenyu Lin, Hao Wang, Xiaojun Luo, 2020, Experimental & Molecular Medicine.

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage

Aimin Li, Yue Luo, Xinhui Liu, 2020, Frontiers in Genetics.

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2

Aimin Li, Hua Xiao, Yue Luo, 2021, Journal of translational medicine.

Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation

Wenyu Lin, R. Chung, K. Hu, 2021, Journal of cellular and molecular medicine.

Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA

Yan Sun, Jun-shuang Jia, Guanqi Dai, 2022, Nature Communications.

Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression

Tao-yan Lin, Jing Li, Wen-tao Zhao, 2023, Aging.

Mettl3-mediated m 6 A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression

Tao-yan Lin, Jing Li, Wen-tao Zhao, 2023 .

LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis

Aimin Li, Yue Luo, Yueqi Zhang, 2020, Cell biochemistry and function.